Amigo AI raises $11m Series A led by Madrona
Madrona leads the clinical AI company’s Series A, with Optum Ventures participating and Jay Shah joining as chief medical advisor.
A new round following the seed financing
Amigo AI announced an $11 million Series A on March 10, 2026, led by Madrona with participation from Optum Ventures. The issuer’s dated announcement put cumulative funding at $17 million, including an earlier seed financing backed by General Catalyst and GSV Ventures.
Clinical leadership and deployment
Alongside the financing, the company named physician and technology executive Jay Shah as chief medical advisor. Amigo said its clinical agents had supported more than three million patient encounters over the preceding six months. The announcement tied the next phase to training and deploying agents for healthcare organizations, using simulated clinical interactions and supervised evaluation.
Use of funds
Train and deploy clinical AI agents for healthcare organizations